Measuring Tensile Strength to Better Establish Protective Capacity of Sacral Prophylactic Dressings Over 7 Days of Laboratory Aging.


Journal

Advances in skin & wound care
ISSN: 1538-8654
Titre abrégé: Adv Skin Wound Care
Pays: United States
ID NLM: 100911021

Informations de publication

Date de publication:
Jul 2019
Historique:
entrez: 21 6 2019
pubmed: 21 6 2019
medline: 2 1 2020
Statut: ppublish

Résumé

Results from large-scale randomized clinical trials support the application of prophylactic dressings to provide protection from body-weight force-induced deformations known to damage skin and underlying tissues, which often result in pressure injuries (pressure ulcers). This laboratory study using a new method for aging dressings in simulated use followed by tensile testing was conducted to further understand the protective effect of sacral prophylactic dressings (SPDs) in alleviating tissue deformations in the sacral region through the course of typical application. Specifically, four SPDs were exposed to a simulation of the clinical environment incorporating saline solution absorption, mechanical loading, and repetitive sliding-induced shear. After aging, the protective endurance of the SPDs was measured through tensile testing to determine their effectiveness against tissue-damaging forces over time.This study uses the concepts of axial stiffness, protective endurance, and elastic limit to describe more accurately the protective aspects of SPDs under dry and moist conditions and how they interact with the skin and underlying tissues over the life of the dressing. The authors propose two primary features in SPD effectiveness in preventing pressure injuries: high conformability (ie, low flexural stiffness) and protective endurance (the dressing's capacity to maintain biomechanical performance when moist).

Identifiants

pubmed: 31219898
doi: 10.1097/01.ASW.0000558694.20067.4f
pii: 00129334-201907001-00004
doi:

Types de publication

Journal Article

Langues

eng

Pagination

S21-S27

Auteurs

Joshua N Burton (JN)

At EC Service, in Centerville, Utah, Joshua N. Burton, MS, PhD(c), is Lead Engineer; Abigail G. Fredrickson is Testing Engineer; Cassidee Capunay, BA, is Technical Writer; and Laurel Tanner, MA, is Lead Technical Writer. Craig Oberg, PhD, is Professor, Department of Microbiology, Weber State University, Ogden, Utah. Nick Santamaria, PhD, RN, is Professor, School of Health Sciences, University of Melbourne, Melbourne, Australia. Amit Gefen, PhD, is Professor, Department of Biomedical Engineering, Tel Aviv University, Israel. Evan Call, MS, CSM (NRM), is Adjunct Professor, Department of Microbiology, Weber State University, Ogden, Utah. Acknowledgment: This study was supported by an unrestricted educational grant from Mölnlycke Healthcare AB, which provided funding and materials for the study outlined in this paper, but has had no bearing on the findings. The authors have disclosed no other financial relationships related to this article. Submitted March 26, 2019; accepted in revised form April 18, 2019.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH